Inge G. Thulin

CIK: 0001263739

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MRK

Merck & Co., Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

MRK
Merck & Co., Inc.
May 29, 2026
Award(A)
Phantom Stock
Direct
1.9K shares at avg. $118.72-
MRK
Merck & Co., Inc.
May 30, 2025
Award(A)
Phantom Stock
Direct
2.9K shares at avg. $76.84-
MRK
Merck & Co., Inc.
Feb 6, 2025
Purchase(P)
Direct
2.8K shares at avg. $88.25$250K

		Type	Shares	Price		Ownership
May 29, 2026	MRK Merck & Co., Inc.	Award(A) Phantom Stock	1,853	$118.72	-	Direct
May 30, 2025	MRK Merck & Co., Inc.	Award(A) Phantom Stock	2,863	$76.84	-	Direct
Feb 6, 2025	MRK Merck & Co., Inc.	Purchase(P)	2,833	$88.25	$250,000	Direct

1-3 of 3 transactions

About THULIN INGE G

THULIN INGE G (SEC CIK 0001263739) files insider reports with the SEC as Director of Merck & Co., Inc. (MRK).

Signal8 holds 3 ownership filings by THULIN INGE G, all Form 4s, filed between Feb 7, 2025 and Jun 2, 2026. Those filings report 3 transactions, from Feb 6, 2025 to May 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on THULIN INGE G's filings is in RAHWAY, NJ.

Recent filings by THULIN INGE G

May 29, 2026: Grant or award of MRK derivative securities (Form 4, code A).
May 30, 2025: Grant or award of MRK derivative securities (Form 4, code A).
Feb 6, 2025: Open-market purchase of MRK shares (Form 4, code P).

Other insiders filing for Merck & Co., Inc. (MRK)

DIAZ PAUL J, Director
Maraldo David R., EVP & Pres. MMD
Seidman Christine E, Director
Karsanbhai Surendralal Lanca, Director
Coe Mary Ellen, Director
Gupta Gaurav K, EVP, CIDO

How to read Form 4 transaction codes